Research-Grant
Research-Grant funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.
NIH Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)
This NIH PAR-26-116 cooperative agreement supports translational research led by extramural investigators that uses NIH Clinical Center infrastructure through a planned collaboration with NIH intramural investigators.
NIH RFA-DA-25-024: High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
NIH NIDA RFA-DA-25-024 supports high-priority research at the intersection of HIV and substance use, including prevention, treatment, cure, and implementation work with R01 funding flexibility and clinical trials optional.
NIH RFA-DA-25-060: High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
NIH NIDA RM1 funding for interdisciplinary teams studying HIV and substance use, prioritizing ambitious team-based proposals with a single transformative goal and up to five years of support.
NSF 25-510: Coupling, Energetics, and Dynamics of Atmospheric Regions (CEDAR)
A recurring NSF Geosciences solicitation for upper-atmosphere and space-plasma coupling research with annual deadlines, typically awarded as standard or continuing grants with up to five-year project terms.
NSF 25-515: Security, Privacy, and Trust in Cyberspace (SaTC 2.0)
NSF program solicitation 25-515 funds interdisciplinary cybersecurity, privacy, and trust research and education; it includes multiple proposal tracks and recurring 2026/2027 target deadlines for full proposals.
NSF 26-510: SBIR/STTR Phase I, Phase II, and Fast-Track Funding for Deep Technologies (2026-2027)
Open NSF solicitation for eligible U.S. small businesses to apply for Phase I, Phase II, and Fast-Track SBIR/STTR grants supporting high-risk deep technologies through 2026-2027 deadlines.
PAR-25-322: Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
NIH’s ESI-focused R01 parent NOFO for projects in a new research direction without preliminary data, with recurring 2026/2027 due dates and up to a 5-year project period.
PAR-25-337: Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01, Clinical Trial Optional)
NIH funding opportunity for translational R01 projects that pair academic and industrial partners to move diagnostics, imaging, and care-delivery technologies toward real end-user use in pre-clinical, clinical, and non-clinical settings, with up to $499,000 direct costs per year for up to 5 years.
PAR-25-415: Support for Research Excellence (SuRE-First) Award (R16)
NIH NIGMS SuRE-First grants provide competitive direct research funding to first-time independent faculty at resource-limited U.S. institutions to build research capacity and involve students in biomedical research.
PAR-26-001: Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for Alcohol, Tobacco, and Other Drugs (ATOD) Use and Misuse in Adult Populations that Experience Health Disparities
A recurring NIH parent announcement for NIH-defined clinical trial R01 projects that test and scale SBIRT/P interventions for ATOD use and misuse among adults affected by health disparities.